Personal and Blog Recap
The second week of January was a little slower-paced outside of my day job. PEI was just recovering before receiving yet another snowstorm last Friday bringing 40cm on top of the roughly 40cm from last week.
I am currently working on a new series of blog posts that I am excited to launch in the coming weeks. I’m hoping to kick off the series next week as some of my 9-5 duties should slow down and I won’t have to go into overdrive to meet the tough deadlines from customers just coming back from the holidays.
Stay tuned - I think a lot of you will be interested in the series!
In the following section, I will outline all transactions in my brokerage accounts as well as cover relevant news around my holdings with the goal of keeping the portfolio as transparent as possible.
In the week starting January 3 2022 I received dividends and distributions from the following holdings:
McCormick & Company (NYSE: MKC)
Altria Group (NYSE: MO)
Realty Income Corporation (NYSE: O)
Medtronic plc (NYSE: MDT)
Illinois Tool Works (NYSE: ITW)
Granite REIT (TSE: GRT.UN)
First National Financial Corporation (TSE: FN)
Algonquin Power & Utilities (TSE: AQN / NYSE: AQN)
Buy and Sell Orders
I did not place or execute any orders this week. My plan is (and has been) to invest a certain amount of capital with every paycheck. Unless there is any special event, where I either reinvest dividends that accumulated in one account or sell a position, this section will only contain an order every other week.
Check back next week to find out about my second transaction for 2022.
I’m still waiting anxiously on my first dividend increase for 2022, but the recent announcement from Blackrock (20% increase) has really hyped up my expectations. If you ever wondered where to track the latest Dividend announcements and increases I’ve got two resources for you:
Another big news story broke on Friday when it became known that Unilever (NYSE: UL) placed several bids to the consumer goods arm of GlaxoSmithKline (NYSE: GSK) to add to their portfolio spanning food and consumer healthcare products. The recent bids have been rejected but assuming they eventually work out a buy, this will be an interesting growth project to follow.
Reads from the Community
Over the course of the week, I had a chance to read a lot of articles from the investing community. Below you can find some of my favorite posts throughout the week.
In ‘What are Canadian Depositary Receipts (CDRs) – Should you invest in CDRs?’ Bob, the author of Tawcan, gives an intro to Canadian Depositary Receipts. While holding several ADRs such as Unilever, and Diageo in my portfolio and having a couple more on my watchlist, I did not know there are Canadian equivalents listed on the NEO Exchange. It was refreshing to discover a new product and I’ll keep an eye out when looking at future additions to my portfolio.
Derek from Engineermyfreedom gave an intro into ‘6 European Dividend Stocks to consider for 2022’. Europe is home to some great companies with a global consumer base and a decent history of dividend growth. My personal favorites from his list are Unilever (NYSE: UL) which I already own, and the two healthcare giants Novartis (NYSE: NVS) and Fresenius Medical Care (NYSE: FMS). However, North-American buyers beware when investing in European stock - depending on the exchange you purchase on, make sure you read up on the tax treaties between countries as double taxation can really dig into your yields.
Check back next week for more reads (or videos) from the personal finance and investing community!
I hope you enjoyed reading through some of these insights into my personal life and portfolio.
I invite you to share your opinions or feedback regarding the series. Are you missing anything? Is there another topic you’d like to see covered? Let me know in the comments below!